Skip to main content

Early detection of cardiotoxicity by 2D and 3D deformation imaging in patients receiving chemotherapy

Abstract

The aim of the present study was to find out whether early cardiac changes in patients receiving chemotherapy can be detected by the conventional and deformation parameters of 2D and 3D echocardiography. Twenty-five healthy subjects with normal regional left ventricular function (group 1) and 25 patients receiving chemotherapy (group 2) underwent 2D and 3D transthoracic echocardiography (Toshiba Artida Medical System). All patients (group 2) were examined before and during cardiotoxic chemotherapy at a 3-month follow-up. Left ventricular volumes, ejection fraction, muscle mass, global longitudinal, global radial, global circumferential strain, and rotation were analyzed with 2D and 3D echocardiography, while twist and time-to-peak-intervals were analyzed with 3D echocardiography. For left ventricular volumes and muscle mass, no significant differences were seen between the two study groups (P<0.05). According to our results, myocardial dysfunction induced by cardiotoxic chemotherapy can be detected by 2D global radial strain. Detecting myocardial dysfunction by global longitudinal and circumferential strain requires more than 3 months follow-up. Changes in rotation, twist or time-to-peak intervals could not be verified at the 3-month follow-up in the present study. 2D global radial strain seems to be the most sensitive and robust parameter to detect early myocardial damage during chemotherapy. 3D echocardiography is not yet an established method to detect myocardial damage in clinical practice due to lower spatial and temporal resolution.

References

  1. Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L 2013 Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. European Journal of Cancer 49 3396–3403. (doi:10.1016/j.ejca.2013.06.046)

    Article  CAS  Google Scholar 

  2. Seidman A, Hudis C, Kathryn Pierri M, Shak S, Paton V, Ashby M, Murphy M, Stewart SJ, Keefe D 2002 Cardiac dysfunction in the trastuzumab clinical trials experience. Journal of Clinical Oncology 20 1215–1221. (doi:10.1200/JCO.20.5.1215)

    Article  CAS  Google Scholar 

  3. Yeh ET, Bickford CL 2009 Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology 53 2231–2247. (doi:10.1016/j.jacc.2009.02.050)

    Article  CAS  Google Scholar 

  4. Gharib MI, Burnett AK 2002 Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. European Journal of Heart Failure 4 235–242. (doi:10.1016/S1388-9842(01)00201-X)

    Article  CAS  Google Scholar 

  5. Tan TC, Scherrer-Crosbie M 2012 Assessing the Cardiac Toxicity of Chemotherapeutic Agents: role of echocardiography. Current Cardiovascular Imaging Reports 5 403–409. (doi:10.1007/s12410-012-9163-3)

    Article  Google Scholar 

  6. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA 2009 Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet. Oncology 10 391–399. (doi:10.1016/S1470-2045(09)70042-7)

    Article  CAS  Google Scholar 

  7. Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, Zamorano J, Nihoyannopoulos P 2008 European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies; European Association of Echocardiography. European Journal of Echocardiography 9 438–448. (doi:10.1093/ejechocard/jen174)

    Article  Google Scholar 

  8. TTE/TEE Appropriateness Criteria Writing Group Douglas PS, Badano LP, Khandheria B, Stainback RF, Weissman NJ, TTE/TEE Appropriateness Criteria Technical Panel Brindis RG, Patel MR, Alpert JS, Fitzgerald D et al. 2007 ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. Journal of the American Society of Echocardiography 20 787–805. (doi:10.1016/j.echo.2007.06.011)

    Article  Google Scholar 

  9. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP et al. 2011 Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Journal of the American Society of Echocardiography 24 277–313. (doi:10.1016/j.echo.2011.01.015)

    Article  Google Scholar 

  10. Feigenbaum H, Mastouri R, Sawada S 2012 A practical approach to using strain echocardiography to evaluate the left ventricle. Circulation Journal 76 1550–1555. (doi:10.1253/circj.CJ-12-0665)

    Article  Google Scholar 

  11. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE et al. 2012 Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circulation. Cardiovascular Imaging 5 596–603. (doi:10.1161/CIRCIMAGING.112.973321)

    Article  Google Scholar 

  12. Stoodley PW, Richards DAB, Hui R, Boyd A, Harnett PR, Meikle SR, Clarke J, Thomas L 2011 Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. European Journal of Echocardiography 12 945–952. (doi:10.1093/ejechocard/jer187)

    Article  Google Scholar 

  13. Ho SY 2009 Anatomy and myoarchitecture of the left ventriculatr wall in morla and in disease. European Journal of Echocardiography 10 iii3–iii4. (doi:10.1093/ejechocard/jen243)

    Article  Google Scholar 

  14. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP et al. 2011 Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. European Journal of Echocardiography 12 167–205. (doi:10.1093/ejechocard/jer021)

    Article  Google Scholar 

  15. Mavinkurve-Groothuis AM, Marcus KA, Pourier M, Loonen J, Feuth T, Hoogerbrugge PM, de Korte CL, Kapusta L 2013 Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study. European Heart Journal Cardiovascular Imaging 14 562–569. (doi:10.1093/ehjci/jes217)

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrienn Tarr.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarr, A., Stoebe, S., Tuennemann, J. et al. Early detection of cardiotoxicity by 2D and 3D deformation imaging in patients receiving chemotherapy. Echo Res Pract 2, 81–88 (2015). https://doi.org/10.1530/ERP-14-0084

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-14-0084

Key Words